These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8638215)

  • 1. One step closer to gene therapy for Parkinson's disease.
    Kolchinsky A
    Surg Neurol; 1996 Mar; 45(3):211-2. PubMed ID: 8638215
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of gene therapy for Parkinson's disease: nonhuman primate experience.
    Bankiewicz KS; Bringas JR; McLaughlin W; Pivirotto P; Hundal R; Yang B; Emborg ME; Nagy D
    Adv Pharmacol; 1998; 42():801-6. PubMed ID: 9328019
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects and gene delivery in a rat model of Parkinson's disease.
    Isacson O
    Science; 1995 Aug; 269(5225):856-7. PubMed ID: 7638605
    [No Abstract]   [Full Text] [Related]  

  • 4. Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.
    Nagatsu T; Nagatsu I
    J Neural Transm (Vienna); 2016 Nov; 123(11):1255-1278. PubMed ID: 27491309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of electroacupuncture scalp point-through-point therapy on the expression of tyrosine hydroxylase and dopamine transporter mRNAs in substantia nigra of Parkinson's disease model rats].
    Wang S; Qi XJ; Han D
    Zhongguo Zhen Jiu; 2009 May; 29(5):391-4. PubMed ID: 19489498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.
    Shen Y; Muramatsu SI; Ikeguchi K; Fujimoto KI; Fan DS; Ogawa M; Mizukami H; Urabe M; Kume A; Nagatsu I; Urano F; Suzuki T; Ichinose H; Nagatsu T; Monahan J; Nakano I; Ozawa K
    Hum Gene Ther; 2000 Jul; 11(11):1509-19. PubMed ID: 10945765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
    Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
    Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of a founder mutation in the TH gene in a cohort of greek patients with Parkinson's disease.
    Pons R; Kekou K; Antonellou R; Svingou M; Kanavakis E; Stefanis L
    Mov Disord; 2016 Nov; 31(11):1753-1754. PubMed ID: 27666733
    [No Abstract]   [Full Text] [Related]  

  • 9. [Present status and future prospects for gene therapy in Parkinson's disease].
    Muramatsu S
    Nihon Naika Gakkai Zasshi; 2003 Aug; 92(8):1461-6. PubMed ID: 13677895
    [No Abstract]   [Full Text] [Related]  

  • 10. The therapeutic effects of tyrosine hydroxylase gene transfected hematopoetic stem cells in a rat model of Parkinson's disease.
    Zhang S; Zou Z; Jiang X; Xu R; Zhang W; Zhou Y; Ke Y
    Cell Mol Neurobiol; 2008 Jun; 28(4):529-43. PubMed ID: 17713852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for Parkinson's disease: do we have the cure?
    Benabid AL
    Lancet Neurol; 2010 Dec; 9(12):1142-1143. PubMed ID: 21087733
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapy for Parkinson's disease: a step closer?
    Stoessl AJ
    Lancet; 2014 Mar; 383(9923):1107-9. PubMed ID: 24412047
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy for Parkinson's disease: still a hot topic?
    Kordower JH
    Neuropsychopharmacology; 2015 Jan; 40(1):255-6. PubMed ID: 25482182
    [No Abstract]   [Full Text] [Related]  

  • 14. Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease.
    Planté-Bordeneuve V; Davis MB; Maraganore DM; Marsden CD; Harding AE
    Mov Disord; 1994 May; 9(3):337-9. PubMed ID: 7913740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy in Parkinson's disease: dream or reality?
    Monville C
    Neuroreport; 2002 May; 13(6):743. PubMed ID: 12030230
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease.
    Horellou P; Vigne E; Castel MN; Barnéoud P; Colin P; Perricaudet M; Delaère P; Mallet J
    Neuroreport; 1994 Dec; 6(1):49-53. PubMed ID: 7703427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of electroacupuncture stimulation of "Fengfu" (GV 16) and "Taichong" (LR 3) on expression of COX-2 and tyrosine hydroxylase in Substantia Nigra in rats with Parkinson's disease].
    Wang SJ; Fang JQ; Ma J; Zhou D; Wang YC; Gan SY; Sun GJ
    Zhen Ci Yan Jiu; 2013 Jun; 38(3):198-201. PubMed ID: 24006664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies.
    Kang UJ
    Mov Disord; 1998; 13 Suppl 1():59-72. PubMed ID: 9613721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal ganglia: new therapeutic approaches to Parkinson's disease.
    Graybiel AM
    Curr Biol; 1996 Apr; 6(4):368-71. PubMed ID: 8723334
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson's disease.
    Corti O; Sánchez-Capelo A; Colin P; Hanoun N; Hamon M; Mallet J
    Proc Natl Acad Sci U S A; 1999 Oct; 96(21):12120-5. PubMed ID: 10518586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.